Comparative pharmacokinetic, immunologic and hematologic studies on the anti-HIV-1/2 compounds aconitylated and succinylated HSA

P. Swart Groningen Institute for Drug Studies, University Centre for Pharmacy, Section Pharmacokinetics and Drug Delivery, A. Deusinglaan 2, 9713Correspondence[email protected]

E. Beljaars Groningen Institute for Drug Studies, University Centre for Pharmacy, Section Pharmacokinetics and Drug Delivery, A. Deusinglaan 2, 9713

C. Smit Groningen Institute for Drug Studies, University Centre for Pharmacy, Section Pharmacokinetics and Drug Delivery, A. Deusinglaan 2, 9713

A. Pasma Groningen Institute for Drug Studies, University Centre for Pharmacy, Section Pharmacokinetics and Drug Delivery, A. Deusinglaan 2, 9713

D. Meijer Groningen Institute for Drug Studies, University Centre for Pharmacy, Section Pharmacokinetics and Drug Delivery, A. Deusinglaan 2, 9713

H. SchuitemakerDepartment of Clinical Viro-Immunology Central Laboratory of the Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology of the University of Amsterdam; Groningen Institute for Drug Studies, University Centre for Pharmacy, Section Pharmacokinetics and Drug Delivery, A. Deusinglaan 2, 9713

Comparative pharmacokinetic, immunologic and hematologic studies on the anti-HIV-1/2 compounds aconitylated and succinylated HSA

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Comparative pharmacokinetic, immunologic and hematologic studies on the anti-HIV-1/2 compounds aconitylated and succinylated HSA

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date